Logo image of AVBP

ARRIVENT BIOPHARMA INC (AVBP) Stock Analyst Ratings

NASDAQ:AVBP - Nasdaq - US04272N1028 - Common Stock - Currency: USD

17.99  -0.55 (-2.97%)

After market: 17.99 0 (0%)

Buy % Consensus

86

ChartMill assigns a Buy % Consensus number of 86% to AVBP. The Buy consensus is the weighted average rating of the current analysts ratings.

Analysts have set a mean price target forecast of 40.19. This target is 123.39% above the current price.
AVBP was analyzed by 16 analysts. The buy percentage consensus is at 86. So analysts seem to be very confident about AVBP.
In the previous month the buy percentage consensus was at a similar level.
AVBP was analyzed by 16 analysts, which is quite many. So the average rating should be quite meaningful.
AVBP Historical Analyst RatingsAVBP Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -17 -15 -13 -11 -9 -7 -5 -3 -1 5 10 15

Price Target & Forecast

Price Low Median Mean High 17.9932.3240.8040.1947.25 - 79.66% 126.79% 123.39% 162.65%
AVBP Current Analyst RatingAVBP Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 2 4 6 8
Up and Down Grades
Date Firm Action Rating
2025-07-22 HC Wainwright & Co. Reiterate Buy -> Buy
2025-07-10 Goldman Sachs Reiterate Buy
2025-06-25 Clear Street Initiate Buy
2025-06-24 Guggenheim Reiterate Buy -> Buy
2025-06-24 Oppenheimer Maintains Outperform -> Outperform
2025-05-20 Jones Trading Initiate Buy
2025-05-14 HC Wainwright & Co. Maintains Buy -> Buy
2025-03-20 B. Riley Securities Initiate Buy
2025-03-10 Guggenheim Initiate Buy
2025-03-07 HC Wainwright & Co. Reiterate Buy -> Buy
2025-01-22 HC Wainwright & Co. Maintains Buy -> Buy
2024-11-15 HC Wainwright & Co. Reiterate Buy -> Buy
2024-09-11 Citigroup Maintains Buy -> Buy
2024-09-10 Oppenheimer Reiterate Outperform -> Outperform
2024-09-10 Goldman Sachs Maintains Buy -> Buy
2024-09-10 HC Wainwright & Co. Maintains Buy -> Buy
2024-08-16 HC Wainwright & Co. Maintains Buy -> Buy
2024-08-15 Oppenheimer Reiterate Outperform -> Outperform
2024-06-06 HC Wainwright & Co. Reiterate Buy -> Buy
2024-05-09 HC Wainwright & Co. Reiterate Buy -> Buy
2024-04-30 HC Wainwright & Co. Initiate Buy
2024-02-20 Goldman Sachs Initiate Buy
2024-02-20 Citigroup Initiate Buy
2024-02-20 Jefferies Initiate Buy